LCTX
Lineage Cell Therapeutics, Inc.
Company overview
- Market capitalization
- $245.57M
- Employees
- 72
- Latest publication
- 2026-09-29
About Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the age-related macular degeneration; and OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for the treatment of cervical spinal cord injuries. It also offers ReSonance (ANP1), an allogeneic auditory neuron progenitor cell transplant, which is in preclinical development for the treatment of sensorineural hearing loss; and PNC1, an allogeneic photoreceptor cell transplant, which is in preclinical development for the treatment of vision loss due to photoreceptor dysfunction or damage. In addition, the company is developing RND1, a novel hypoimmune induced pluripotent stem cell line for the development of a cell transplant candidate for the potential treatment of an undisclosed indication, as well as engages in the research and development of ILT1, an allogeneic cell transplant for the treatment of Type 1 Diabetes; and LCT-CON, an allogeneic cell transplant, as well as therapeutic products for retinal diseases, neurological diseases, ophthalmology, metabolic, and disorders and oncology. The company has a collaboration agreement with William Demant Invest for the preclinical development of ReSonance (ANP1). It also has a strategic collaboration with Factor Bioscience Inc. for the development of genetically engineered iPSC line for the company to utilize for differentiation into certain cell transplant product candidates. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was incorporated in 1990 and is headquartered in Carlsbad, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,725,000USD | 6,608,000USD | 3,681,000USD | 2,765,000USD | 1,502,000USD | 2,868,000USD | 3,779,000USD | 1,408,000USD |
| Cost Of Revenue | 188,000USD | 66,000USD | 5,000USD | 39,000USD | 36,000USD | 154,000USD | 38,000USD | 44,000USD |
| Gross Profit | 1,537,000USD | 6,542,000USD | 3,676,000USD | 2,726,000USD | 1,466,000USD | 2,714,000USD | 3,741,000USD | 1,364,000USD |
| Research Development | 4,234,000USD | 8,238,000USD | 3,271,000USD | 3,106,000USD | 3,114,000USD | 3,423,000USD | 3,171,000USD | 2,868,000USD |
| Selling General Administrative | 5,084,000USD | 4,852,000USD | 4,191,000USD | 4,560,000USD | 4,857,000USD | 4,401,000USD | 4,410,000USD | 4,363,000USD |
| Total Operating Expenses | 9,130,000USD | 13,090,000USD | 7,462,000USD | 22,506,000USD | 7,971,000USD | 7,824,000USD | 7,581,000USD | 7,231,000USD |
| Operating Income | -7,593,000USD | -6,548,000USD | -3,786,000USD | -19,780,000USD | -6,505,000USD | -5,110,000USD | -3,840,000USD | -5,867,000USD |
| Interest Income | 405,000USD | 393,000USD | 366,000USD | 454,000USD | 478,000USD | 393,000USD | 397,000USD | 463,000USD |
| Net Interest Income | 405,000USD | 393,000USD | 366,000USD | 454,000USD | 478,000USD | 393,000USD | 397,000USD | 463,000USD |
| Income Before Tax | -4,789,000USD | -4,388,000USD | -29,752,000USD | -30,364,000USD | -4,143,000USD | -3,250,000USD | -3,001,000USD | -5,773,000USD |
| Net Income | -4,812,000USD | 851,000USD | -29,781,000USD | -30,464,000USD | -4,139,000USD | -3,273,000USD | -3,034,000USD | -5,760,000USD |
| Net Income From Continuing Ops | -4,789,000USD | 892,000USD | -29,752,000USD | -30,364,000USD | -4,143,000USD | -3,250,000USD | -3,001,000USD | -5,773,000USD |
| Ebit | -7,593,000USD | -6,548,000USD | -29,752,000USD | -4,940,000USD | -6,505,000USD | -5,110,000USD | -3,840,000USD | -5,867,000USD |
| Ebitda | -7,405,000USD | -6,362,000USD | -29,574,000USD | -4,769,000USD | -6,341,000USD | -4,959,000USD | -3,699,000USD | -5,725,000USD |
| Depreciation And Amortization | 188,000USD | 186,000USD | 178,000USD | 171,000USD | 164,000USD | 151,000USD | 141,000USD | 142,000USD |
| Reconciled Depreciation | 188,000USD | 186,000USD | 178,000USD | 171,000USD | 164,000USD | 151,000USD | 141,000USD | 142,000USD |
| Total Other Income Expense Net | 2,804,000USD | 2,160,000USD | -25,966,000USD | -10,584,000USD | 2,362,000USD | 1,860,000USD | 839,000USD | 94,000USD |
| Minority Interest | -23,000USD | -41,000USD | -29,000USD | -100,000USD | 4,000USD | -23,000USD | -33,000USD | 13,000USD |
| Income Tax Expense | — | -5,280,000USD | — | — | — | 10,000USD | 33,000USD | -13,000USD |
| Unclassified Operating Expenses | — | — | — | 14,840,000USD | — | — | — | — |
| Tax Provision | — | — | — | — | — | 0USD | 0USD | 0USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 142,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 14,556,000USD | 9,499,000USD | 8,945,000USD | 14,703,000USD | 3,896,000USD | 773,000USD | 1,478,000USD | 1,416,000USD |
| Cost Of Revenue | 845,000USD | 334,000USD | 671,000USD | 728,000USD | 1,426,000USD | 385,000USD | 412,000USD | 302,000USD |
| Gross Profit | 13,711,000USD | 9,165,000USD | 8,274,000USD | 13,975,000USD | 2,470,000USD | 388,000USD | 1,066,000USD | 1,114,000USD |
| Research Development | 17,729,000USD | 12,472,000USD | 15,705,000USD | 13,987,000USD | 33,914,000USD | 12,317,000USD | 17,948,000USD | 20,955,000USD |
| Selling General Administrative | 18,460,000USD | 18,171,000USD | 17,302,000USD | 22,508,000USD | 18,212,000USD | 15,571,000USD | 24,031,000USD | 24,726,000USD |
| Total Operating Expenses | 35,490,000USD | 30,643,000USD | 33,007,000USD | 36,495,000USD | 51,681,000USD | 26,835,000USD | 39,942,000USD | 42,109,000USD |
| Operating Income | -21,779,000USD | -21,478,000USD | -24,733,000USD | -22,520,000USD | -49,211,000USD | -26,447,000USD | -38,876,000USD | -41,795,000USD |
| Interest Income | 1,691,000USD | 1,715,000USD | 1,629,000USD | 829,000USD | 2,000USD | 1,039,000USD | 17,110,000USD | 82,531,000USD |
| Net Interest Income | 1,691,000USD | 1,715,000USD | 1,629,000USD | 829,000USD | 2,000USD | 1,039,000USD | 1,685,000USD | 711,000USD |
| Income Before Tax | -68,647,000USD | -18,582,000USD | -23,282,000USD | -25,812,000USD | -43,270,000USD | -21,924,000USD | -19,234,000USD | -47,130,000USD |
| Income Tax Expense | -5,114,000USD | 27,000USD | -1,803,000USD | 541,000USD | -4,706,000USD | -1,239,000USD | -7,407,000USD | -346,000USD |
| Tax Provision | -5,280,000USD | 0USD | -1,803,000USD | 541,000USD | -2,242,000USD | -1,239,000USD | -7,407,000USD | -346,000USD |
| Net Income | -63,533,000USD | -18,609,000USD | -21,486,000USD | -26,273,000USD | -43,019,000USD | -20,649,000USD | -11,709,000USD | -45,990,000USD |
| Net Income From Continuing Ops | -63,367,000USD | -18,582,000USD | -21,479,000USD | -26,353,000USD | -43,270,000USD | -20,685,000USD | -26,641,000USD | -46,784,000USD |
| Ebit | -21,779,000USD | -21,478,000USD | -24,733,000USD | -22,520,000USD | -49,211,000USD | -26,447,000USD | -38,876,000USD | -40,995,000USD |
| Ebitda | -21,080,000USD | -20,869,000USD | -24,041,000USD | -21,793,000USD | -48,338,000USD | -24,408,000USD | -35,876,000USD | -37,722,000USD |
| Depreciation And Amortization | 699,000USD | 609,000USD | 692,000USD | 727,000USD | 873,000USD | 2,039,000USD | 3,000,000USD | 3,273,000USD |
| Reconciled Depreciation | 699,000USD | 609,000USD | 692,000USD | 727,000USD | 887,000USD | 2,111,000USD | 3,129,000USD | 3,273,000USD |
| Total Other Income Expense Net | -46,868,000USD | 2,896,000USD | 1,451,000USD | -3,292,000USD | 5,941,000USD | 4,523,000USD | 19,642,000USD | -5,335,000USD |
| Minority Interest | -166,000USD | -27,000USD | -7,000USD | -80,000USD | -251,000USD | -36,000USD | -118,000USD | -794,000USD |
| Selling And Marketing Expenses | — | — | 562,001USD | — | — | — | — | — |
| Interest Expense | — | — | — | 5,181,000USD | 2,000USD | 5,163,000USD | 1,685,000USD | 10,872,000USD |
| Non Operating Income Net Other | — | — | — | -4,121,000USD | 5,939,000USD | 4,523,000USD | 17,957,000USD | -6,046,000USD |
| Net Income Applicable To Common Shares | — | — | — | -26,273,000USD | -43,019,000USD | -20,649,000USD | -11,709,000USD | -45,990,000USD |
| Unclassified Operating Expenses | — | — | — | — | — | -1,053,000USD | -2,037,000USD | -3,572,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 109,533,000USD | 112,584,000USD | 89,639,000USD | 90,799,000USD | 111,753,000USD | 113,218,000USD | 96,594,000USD | 102,802,000USD |
| Intangible Assets | 31,700,000USD | 31,700,000USD | 31,700,000USD | 31,700,000USD | 46,540,000USD | 46,540,000USD | 46,540,000USD | 46,540,000USD |
| Other Current Assets | 1,977,000USD | 1,814,000USD | 1,647,000USD | 1,300,000USD | 1,866,000USD | 2,554,000USD | 1,285,000USD | 1,659,000USD |
| Total Liab | 56,838,000USD | 69,238,000USD | 68,843,000USD | 43,687,000USD | 34,098,000USD | 36,206,000USD | 31,800,000USD | 35,927,000USD |
| Total Stockholder Equity | 53,875,000USD | 44,549,000USD | 22,040,000USD | 48,385,000USD | 79,028,000USD | 78,381,000USD | 66,186,000USD | 68,300,000USD |
| Other Current Liab | 5,567,000USD | 4,840,000USD | 3,766,000USD | 2,954,000USD | 2,983,000USD | 4,263,000USD | 2,878,000USD | 2,630,000USD |
| Common Stock | 529,655,999USD | 515,467,000USD | 494,175,000USD | 490,551,000USD | 489,313,000USD | 484,722,000USD | 469,268,000USD | 467,928,000USD |
| Capital Stock | 529,656,000USD | 515,467,000USD | 494,175,000USD | 490,551,000USD | 489,313,000USD | 484,722,000USD | 469,268,000USD | 467,928,000USD |
| Retained Earnings | -471,810,000USD | -466,998,000USD | -467,849,000USD | -438,068,000USD | -407,604,000USD | -403,465,000USD | -400,192,000USD | -397,158,000USD |
| Good Will | 10,672,000USD | 10,672,000USD | 10,672,000USD | 10,672,000USD | 10,672,000USD | 10,672,000USD | 10,672,000USD | 10,672,000USD |
| Cash | 35,939,000USD | 40,791,000USD | 40,463,000USD | 42,271,000USD | 47,886,000USD | 45,789,000USD | 27,750,000USD | 29,622,000USD |
| Cash And Short Term Investments | 53,381,000USD | 55,781,000USD | 40,486,000USD | 42,288,000USD | 47,905,000USD | 47,805,000USD | 32,711,000USD | 38,496,000USD |
| Total Current Assets | 56,164,000USD | 59,157,000USD | 42,260,000USD | 43,844,000USD | 49,984,000USD | 50,997,000USD | 34,401,000USD | 40,390,000USD |
| Total Current Liabilities | 8,148,000USD | 11,367,000USD | 9,382,000USD | 10,756,000USD | 13,089,000USD | 13,977,000USD | 13,864,000USD | 15,275,000USD |
| Current Deferred Revenue | 1,716,000USD | 3,333,000USD | 3,766,000USD | 5,257,000USD | 6,931,000USD | 7,388,000USD | 8,250,000USD | 9,142,000USD |
| Net Debt | -33,545,000USD | -38,372,000USD | -37,842,000USD | -40,117,000USD | -45,642,000USD | -43,275,000USD | -25,000,000USD | -26,671,000USD |
| Short Term Debt | 865,000USD | 853,000USD | 1,066,000USD | 1,048,000USD | 1,180,000USD | 1,152,000USD | 1,137,000USD | 1,115,000USD |
| Short Long Term Debt Total | 2,394,000USD | 2,419,000USD | 2,621,000USD | 2,154,000USD | 2,244,000USD | 2,514,000USD | 2,750,000USD | 2,951,000USD |
| Short Term Investments | 17,442,000USD | 14,990,000USD | 23,000USD | 17,000USD | 19,000USD | 2,016,000USD | 4,961,000USD | 8,874,000USD |
| Net Receivables | 806,000USD | 1,562,000USD | 127,000USD | 256,000USD | 213,000USD | 638,000USD | 405,000USD | 235,000USD |
| Accounts Payable | 5,567,000USD | 2,341,000USD | 4,550,000USD | 1,497,000USD | 1,995,000USD | 1,174,000USD | 1,599,000USD | 2,388,000USD |
| Property Plant Equipment Net | 4,624,000USD | 4,697,000USD | 4,468,000USD | 4,072,000USD | 4,053,000USD | 4,395,000USD | 4,375,000USD | 4,602,000USD |
| Property Plant Equipment Gross | 10,270,000USD | 10,381,000USD | 9,797,000USD | 9,132,000USD | 8,521,000USD | 8,779,000USD | 8,568,000USD | 8,638,000USD |
| Accumulated Other Comprehensive Income | -7,942,000USD | -3,920,000USD | -4,286,000USD | -4,098,000USD | -2,681,000USD | -2,876,000USD | -2,890,000USD | -2,470,000USD |
| Common Stock Shares Outstanding | 261,175,000shares | 230,116,000shares | 228,853,000shares | 228,356,000shares | 226,054,000shares | 200,193,000shares | 188,835,000shares | 188,813,000shares |
| Non Current Assets Total | 53,369,000USD | 53,427,000USD | 47,379,000USD | 46,955,000USD | 61,769,000USD | 62,221,000USD | 62,193,000USD | 62,412,000USD |
| Non Current Liabilities Total | 48,690,000USD | 57,871,000USD | 59,461,000USD | 32,931,000USD | 21,009,000USD | 22,229,000USD | 17,936,000USD | 20,652,000USD |
| Non Currrent Assets Other | 36,000USD | 558,000USD | 539,000USD | 511,000USD | 504,000USD | 614,000USD | 606,000USD | 598,000USD |
| Net Working Capital | 48,016,000USD | 47,790,000USD | 32,878,000USD | 33,088,000USD | 36,895,000USD | 37,020,000USD | 20,537,000USD | 25,115,000USD |
| Unclassified Non Current Assets | 6,337,000USD | 5,800,000USD | — | — | — | — | — | — |
| Unclassified Current Liabilities | -5,567,000USD | — | -3,766,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | 48,690,000USD | 57,871,000USD | 59,461,000USD | 32,931,000USD | 21,009,000USD | 22,229,000USD | 17,936,000USD | 20,652,000USD |
| Unclassified Equity | -525,684,999USD | -515,467,000USD | -494,175,000USD | -490,551,000USD | -489,313,000USD | -484,722,000USD | -469,268,000USD | -467,928,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 112,584,000USD | 113,218,000USD | 101,019,000USD | 123,664,000USD | 174,545,000USD | 107,949,000USD | 125,478,000USD | 101,660,000USD |
| Intangible Assets | 31,700,000USD | 46,540,000USD | 46,562,000USD | 46,692,000USD | 46,822,000USD | 47,032,000USD | 48,248,000USD | 3,125,000USD |
| Other Current Assets | 1,814,000USD | 2,554,000USD | 2,204,000USD | 1,828,000USD | 2,351,000USD | 2,433,000USD | 2,063,000USD | 1,898,000USD |
| Total Liab | 69,238,000USD | 36,206,000USD | 38,996,000USD | 51,728,000USD | 83,647,000USD | 12,822,000USD | 14,231,000USD | 9,414,000USD |
| Total Stockholder Equity | 44,549,000USD | 78,381,000USD | 63,419,000USD | 73,339,000USD | 92,221,000USD | 96,199,000USD | 112,959,000USD | 93,840,000USD |
| Other Current Liab | 4,840,000USD | 4,263,000USD | 4,220,000USD | 6,215,000USD | 24,623,000USD | 3,680,000USD | 2,799,000USD | 4,104,000USD |
| Common Stock | 515,467,000USD | 484,722,000USD | 451,343,000USD | 440,280,000USD | 434,529,000USD | 393,944,000USD | 387,062,000USD | 354,270,000USD |
| Capital Stock | 515,467,000USD | 484,722,000USD | 451,343,000USD | 440,280,000USD | 434,529,000USD | 393,944,000USD | 387,062,000USD | 354,270,000USD |
| Retained Earnings | -466,998,000USD | -403,465,000USD | -384,856,000USD | -363,370,000USD | -337,097,000USD | -294,078,000USD | -273,422,000USD | -261,856,000USD |
| Good Will | 10,672,000USD | 10,672,000USD | 10,672,000USD | 10,672,000USD | 10,672,000USD | 10,672,000USD | 10,672,000USD | — |
| Cash | 40,791,000USD | 45,789,000USD | 35,442,000USD | 11,355,000USD | 55,742,000USD | 32,585,000USD | 9,497,000USD | 23,587,000USD |
| Cash And Short Term Investments | 55,781,000USD | 47,805,000USD | 35,492,000USD | 57,875,000USD | 58,358,000USD | 41,562,000USD | 30,716,000USD | 30,741,000USD |
| Total Current Assets | 59,157,000USD | 50,997,000USD | 38,441,000USD | 60,000,000USD | 111,549,000USD | 43,999,000USD | 57,519,000USD | 36,358,000USD |
| Total Current Liabilities | 11,367,000USD | 13,977,000USD | 17,960,000USD | 18,981,000USD | 47,116,000USD | 7,769,000USD | 6,494,000USD | 6,812,000USD |
| Current Deferred Revenue | 3,333,000USD | 7,388,000USD | 10,808,000USD | 9,421,000USD | 18,119,000USD | 193,000USD | 45,000USD | 42,000USD |
| Net Debt | -38,372,000USD | -43,275,000USD | -32,490,000USD | -7,459,000USD | -52,940,000USD | -28,760,000USD | -4,329,000USD | -21,322,000USD |
| Short Term Debt | 853,000USD | 1,152,000USD | 882,000USD | 952,000USD | 831,000USD | 1,285,000USD | 1,223,000USD | 307,000USD |
| Short Long Term Debt Total | 2,419,000USD | 2,514,000USD | 2,952,000USD | 3,896,000USD | 2,802,000USD | 3,825,000USD | 5,168,000USD | 2,265,000USD |
| Short Term Investments | 14,990,000USD | 2,016,000USD | 50,000USD | 46,520,000USD | 2,616,000USD | 8,977,000USD | 21,219,000USD | 7,154,000USD |
| Net Receivables | 1,562,000USD | 638,000USD | 745,000USD | 297,000USD | 50,840,000USD | 4,000USD | 24,740,000USD | 3,719,000USD |
| Accounts Payable | 2,341,000USD | 1,174,000USD | 2,050,000USD | 2,393,000USD | 3,543,000USD | 2,611,000USD | 2,427,000USD | 2,359,000USD |
| Property Plant Equipment Net | 4,697,000USD | 4,395,000USD | 4,767,000USD | 5,673,000USD | 4,872,000USD | 5,630,000USD | 8,175,000USD | 5,835,000USD |
| Property Plant Equipment Gross | 10,381,000USD | 8,779,000USD | 12,005,000USD | 11,523,000USD | 10,174,000USD | 5,630,000USD | 8,175,000USD | 5,835,000USD |
| Accumulated Other Comprehensive Income | -3,920,000USD | -2,876,000USD | -3,068,000USD | -3,571,000USD | -5,211,000USD | -3,667,000USD | -681,000USD | 1,426,000USD |
| Common Stock Shares Outstanding | 230,116,000shares | 200,193,000shares | 172,663,000shares | 169,792,000shares | 164,502,000shares | 150,044,000shares | 145,533,000shares | 126,903,000shares |
| Non Current Assets Total | 53,427,000USD | 62,221,000USD | 62,578,000USD | 63,664,000USD | 62,996,000USD | 63,950,000USD | 67,959,000USD | 65,302,000USD |
| Non Current Liabilities Total | 57,871,000USD | 22,229,000USD | 21,036,000USD | 32,747,000USD | 36,531,000USD | 5,053,000USD | 7,737,000USD | 2,602,000USD |
| Non Currrent Assets Other | 558,000USD | 614,000USD | 577,000USD | 627,000USD | 630,000USD | 616,000USD | 764,000USD | 505,000USD |
| Net Working Capital | 47,790,000USD | 37,020,000USD | 20,481,000USD | 41,019,000USD | 64,433,000USD | 36,230,000USD | 51,025,000USD | 29,546,000USD |
| Unclassified Non Current Assets | 5,800,000USD | — | — | — | — | — | — | -22,609,000USD |
| Unclassified Non Current Liabilities | 57,871,000USD | 22,229,000USD | 21,036,000USD | -29,803,000USD | -34,560,000USD | -2,513,000USD | -3,792,000USD | 1,558,000USD |
| Unclassified Equity | -515,467,000USD | -484,722,000USD | -451,343,000USD | -440,280,000USD | -434,529,000USD | -393,944,000USD | -387,062,000USD | -354,270,000USD |
| Deferred Long Term Liab | — | — | — | 29,801,000USD | 34,530,000USD | 2,076,000USD | 3,515,000USD | — |
| Other Liab | — | — | — | 29,803,000USD | 34,560,000USD | 2,513,000USD | 3,792,000USD | 644,000USD |
| Other Assets | — | — | — | 627,000USD | 630,000USD | 616,000USD | 864,000USD | 22,609,000USD |
| Inventory | — | — | — | 1USD | — | — | 1USD | 1USD |
| Non Current Liabilities Other | — | — | — | 2,946,000USD | 2,001,000USD | 2,977,000USD | 4,222,000USD | 400,000USD |
| Net Tangible Assets | — | — | — | 15,975,000USD | 34,727,000USD | 38,495,000USD | 54,039,000USD | 90,715,000USD |
| Short Long Term Debt | — | — | — | — | — | 523,000USD | — | 70,000USD |
| Long Term Investments | — | — | — | — | — | — | 0USD | 55,837,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4,812,000USD | 951,000USD | -29,781,000USD | -30,364,000USD | -4,143,000USD | -3,273,000USD | -3,034,000USD | -5,760,000USD |
| Depreciation | 188,000USD | 186,000USD | 178,000USD | 171,000USD | 164,000USD | 151,000USD | 141,000USD | 142,000USD |
| Stock Based Compensation | 1,172,000USD | 1,098,000USD | 1,199,000USD | 1,238,000USD | 1,217,000USD | 1,315,000USD | 1,330,000USD | 1,269,000USD |
| Other Non Cash Items | -1,335,999USD | -1,916,000USD | 26,051,000USD | 25,768,000USD | -1,856,000USD | -1,522,000USD | -6,261,000USD | 281,000USD |
| Change To Account Receivables | 154,000USD | -827,000USD | 130,000USD | -43,000USD | 424,000USD | -233,000USD | -329,000USD | -160,000USD |
| Change In Working Capital | -2,118,000USD | 83,000USD | -64,000USD | -2,352,000USD | -268,000USD | -3,017,000USD | 2,037,000USD | -1,108,000USD |
| Total Cash From Operating Activities | -8,077,999USD | -4,878,000USD | -3,616,000USD | -5,539,000USD | -4,886,000USD | -6,346,000USD | -5,787,000USD | -5,176,000USD |
| Capital Expenditures | -55,000USD | -111,000USD | -12,000USD | -14,000USD | -97,000USD | -365,000USD | -88,000USD | -50,000USD |
| Free Cash Flow | -8,132,999USD | -4,989,000USD | -3,628,000USD | -5,553,000USD | -4,983,000USD | -6,711,000USD | -5,699,000USD | -5,226,000USD |
| Investments | -2,271,000USD | -14,935,000USD | -12,000USD | -14,000USD | 1,903,000USD | 2,635,000USD | 3,888,000USD | -8,793,000USD |
| Total Cashflows From Investing Activities | -2,326,000USD | -15,334,000USD | -12,000USD | -14,000USD | 1,903,000USD | 2,635,000USD | 3,888,000USD | -8,793,000USD |
| Net Borrowings | -14,000USD | -15,000USD | -16,000USD | -14,000USD | -14,000USD | -14,000USD | -13,000USD | — |
| Total Cash From Financing Activities | 5,561,000USD | 20,379,000USD | 1,834,000USD | -307,000USD | 5,044,000USD | 21,734,000USD | -3,000USD | 105,000USD |
| Sale Purchase Of Stock | -40,000USD | -1,000USD | 0USD | 0USD | -15,000USD | 0USD | 23,000USD | 0USD |
| Issuance Of Capital Stock | 0USD | 19,632,000USD | 1,276,000USD | -65,000USD | 5,297,000USD | 21,806,000USD | 113,000USD | 33,000USD |
| Change In Cash | -4,852,000USD | 347,000USD | -1,798,000USD | -5,567,000USD | 1,988,000USD | 18,048,000USD | -1,864,000USD | -13,952,000USD |
| Begin Period Cash Flow | 40,791,000USD | 40,977,000USD | 42,775,000USD | 48,342,000USD | 46,354,000USD | 28,306,000USD | 30,170,000USD | 44,122,000USD |
| End Period Cash Flow | 35,939,000USD | 41,324,000USD | 40,977,000USD | 42,775,000USD | 48,342,000USD | 46,354,000USD | 28,306,000USD | 30,170,000USD |
| Other Cashflows From Investing Activities | -55,000USD | -288,000USD | -123,000USD | -14,000USD | -97,000USD | — | -200,000USD | — |
| Other Cashflows From Financing Activities | -40,000USD | -1,000USD | 1,850,000USD | -228,000USD | -224,000USD | -58,000USD | 10,000USD | 86,000USD |
| Unclassified Operating Cash Flow | -1,172,000USD | -5,280,000USD | -1,199,000USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | 5,655,000USD | 20,396,000USD | — | — | 5,297,000USD | 21,806,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -63,533,000USD | -18,609,000USD | -21,486,000USD | -26,353,000USD | -43,270,000USD | -20,685,000USD | -11,827,000USD | -46,784,000USD |
| Depreciation | 699,000USD | 609,000USD | 692,000USD | 727,000USD | 873,000USD | 2,039,000USD | 3,000,000USD | 3,273,000USD |
| Stock Based Compensation | 4,752,000USD | 5,077,000USD | 4,640,000USD | 4,287,000USD | 3,519,000USD | 2,227,000USD | 3,580,000USD | 5,402,000USD |
| Other Non Cash Items | 48,553,000USD | -1,403,000USD | 195,000USD | 3,729,000USD | 202,000USD | -3,468,000USD | -17,337,000USD | 6,935,000USD |
| Change To Account Receivables | -316,000USD | 106,000USD | -446,000USD | 50,314,000USD | -857,000USD | 287,000USD | 467,000USD | 46,000USD |
| Change In Working Capital | -4,110,000USD | -8,766,000USD | -10,804,000USD | 18,669,000USD | 21,110,000USD | 1,373,000USD | -1,956,000USD | 638,000USD |
| Total Cash From Operating Activities | -18,919,000USD | -23,092,000USD | -28,566,000USD | 1,059,000USD | -23,561,000USD | -19,753,000USD | -31,947,000USD | -30,882,000USD |
| Capital Expenditures | -522,000USD | -565,000USD | -674,000USD | -413,000USD | -354,000USD | -64,000USD | -440,000USD | -3,287,000USD |
| Free Cash Flow | -19,441,000USD | -23,657,000USD | -29,240,000USD | 646,000USD | -23,915,000USD | -19,817,000USD | -32,387,000USD | -34,169,000USD |
| Investments | -12,935,000USD | -2,308,000USD | 46,449,000USD | -45,746,000USD | 9,745,000USD | 13,038,000USD | 16,957,000USD | 3,215,000USD |
| Total Cashflows From Investing Activities | -13,457,000USD | -2,308,000USD | 46,449,000USD | -46,159,000USD | 9,745,000USD | 13,038,000USD | 16,957,000USD | 11,816,000USD |
| Net Borrowings | -59,000USD | -54,000USD | -54,000USD | -32,000USD | -20,000USD | 24,624,000USD | -70,000USD | -349,000USD |
| Total Cash From Financing Activities | 26,950,000USD | 35,857,000USD | 6,423,000USD | 1,632,000USD | 36,930,000USD | 29,865,000USD | 617,000USD | 5,774,000USD |
| Sale Purchase Of Stock | -16,000USD | -23,000USD | -37,000USD | -17,000USD | -54,000USD | -27,000USD | -110,000USD | -241,000USD |
| Issuance Of Capital Stock | 26,140,000USD | 35,876,000USD | 6,625,000USD | 148,000USD | 30,865,000USD | 5,127,000USD | 103,000USD | 6,000,000USD |
| Change In Cash | -5,030,000USD | 10,362,000USD | 24,056,000USD | -44,341,000USD | 23,094,000USD | 23,087,000USD | -14,303,000USD | -13,286,000USD |
| Begin Period Cash Flow | 46,354,000USD | 35,992,000USD | 11,936,000USD | 56,277,000USD | 33,183,000USD | 10,096,000USD | 24,399,000USD | 37,685,000USD |
| End Period Cash Flow | 41,324,000USD | 46,354,000USD | 35,992,000USD | 11,936,000USD | 56,277,000USD | 33,183,000USD | 10,096,000USD | 24,399,000USD |
| Other Cashflows From Investing Activities | -522,000USD | -565,000USD | — | -45,746,000USD | 10,099,000USD | 13,102,000USD | 17,397,000USD | -8,000USD |
| Other Cashflows From Financing Activities | -16,000USD | 58,000USD | -111,000USD | 1,533,000USD | 13,379,000USD | 49,938,000USD | 764,000USD | 35,773,000USD |
| Unclassified Operating Cash Flow | -5,280,000USD | — | -1,803,000USD | — | -5,995,000USD | -1,239,000USD | -7,407,000USD | — |
| Unclassified Financing Cash Flow | 27,041,000USD | 35,876,000USD | 6,662,000USD | — | 30,865,000USD | -19,523,000USD | — | 5,000,000USD |
| Unclassified Investing Cash Flow | — | 1,130,000USD | — | 45,746,000USD | -9,745,000USD | -13,038,000USD | -16,957,000USD | 11,896,000USD |
| Dividends Paid | — | — | -37,000USD | — | -7,240,000USD | -25,147,000USD | -40,000USD | -34,409,000USD |
| Change To Liabilities | — | — | — | -18,702,000USD | 21,645,000USD | 308,000USD | -2,885,000USD | 1,100,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -43,468,000USD | 23,114,000USD | 23,150,000USD | -14,373,000USD | -13,292,000USD |
| Change To Inventory | — | — | — | — | -72,000USD | -308,000USD | 2,885,000USD | 122,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Collaboration Revenues | 1,575,000 | USD | 0001193125-26-219479 |
| Q1 2026Quarterly · 2026-03-31 | Product | Royalties License And Other Revenues | 150,000 | USD | 0001193125-26-219479 |
| Q4 2025Quarterly · 2025-12-31 | Product | Collaboration Revenues | 6,263,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Royalties License And Other Revenues | 345,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Collaboration Revenues | 13,609,000 | USD | 0001193125-26-093992 |
| FY 2025Yearly · 2025-12-31 | Product | Royalties License And Other Revenues | 947,000 | USD | 0001193125-26-093992 |
| Q3 2025Quarterly · 2025-09-30 | Product | Collaboration Revenues | 3,544,000 | USD | 0001193125-25-269599 |
| Q3 2025Quarterly · 2025-09-30 | Product | Royalties License And Other Revenues | 137,000 | USD | 0001193125-25-269599 |
| Q2 2025Quarterly · 2025-06-30 | Product | Collaboration Revenues | 2,532,000 | USD | 0000950170-25-107333 |
| Q2 2025Quarterly · 2025-06-30 | Product | Royalties License And Other Revenues | 233,000 | USD | 0000950170-25-107333 |
| Q1 2025Quarterly · 2025-03-31 | Product | Collaboration Revenues | 1,270,000 | USD | 0001193125-26-219479 |
| Q1 2025Quarterly · 2025-03-31 | Product | Royalties License And Other Revenues | 232,000 | USD | 0001193125-26-219479 |
| Q4 2024Quarterly · 2024-12-31 | Product | Collaboration Revenues | 2,478,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Royalties License And Other Revenues | 390,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Collaboration Revenues | 8,149,000 | USD | 0001193125-26-093992 |
| FY 2024Yearly · 2024-12-31 | Product | Royalties License And Other Revenues | 1,350,000 | USD | 0001193125-26-093992 |
| Q3 2024Quarterly · 2024-09-30 | Product | Collaboration Revenues | 3,386,000 | USD | 0001193125-25-269599 |
| Q3 2024Quarterly · 2024-09-30 | Product | Royalties License And Other Revenues | 393,000 | USD | 0001193125-25-269599 |
| Q2 2024Quarterly · 2024-06-30 | Product | Collaboration Revenues | 1,098,000 | USD | 0000950170-25-107333 |
| Q2 2024Quarterly · 2024-06-30 | Product | Royalties License And Other Revenues | 310,000 | USD | 0000950170-25-107333 |
| FY 2023Yearly · 2023-12-31 | Product | Collaboration Revenues | 7,588,000 | USD | 0000950170-25-036309 |
| FY 2023Yearly · 2023-12-31 | Product | Royalties License And Other Revenues | 1,357,000 | USD | 0000950170-25-036309 |
| FY 2022Yearly · 2022-12-31 | Product | Collaboration Revenues | 13,367,000 | USD | 0001493152-23-007129 |
| FY 2022Yearly · 2022-12-31 | Product | Royalties | 1,336,000 | USD | 0001493152-23-007129 |
| FY 2021Yearly · 2021-12-31 | Product | Collaboration Revenues | 1,120,000 | USD | 0001493152-23-007129 |
| FY 2021Yearly · 2021-12-31 | Product | Grant Revenues | 445,000 | USD | 0001493152-23-007129 |
| FY 2021Yearly · 2021-12-31 | Product | Royalties | 2,776,000 | USD | 0001493152-23-007129 |
| FY 2021Yearly · 2021-12-31 | Geography | Foreign | 446,000 | USD | 0001493152-23-007129 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 3,895,000 | USD | 0001493152-23-007129 |
| FY 2020Yearly · 2020-12-31 | Product | Grant Revenues | 1,053,000 | USD | 0001493152-22-006520 |
| FY 2020Yearly · 2020-12-31 | Product | Royalties | 773,000 | USD | 0001493152-22-006520 |
| FY 2020Yearly · 2020-12-31 | Geography | Foreign | 666,000 | USD | 0001493152-22-006520 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 1,160,000 | USD | 0001493152-22-006520 |
| FY 2019Yearly · 2019-12-31 | Product | Grant | 2,037,000 | USD | 0001493152-21-005814 |
| FY 2019Yearly · 2019-12-31 | Product | Royalties From Product Sales And License Fees | 1,221,000 | USD | 0001493152-21-005814 |
| FY 2019Yearly · 2019-12-31 | Product | Sale Of Research Products And Services | 257,000 | USD | 0001493152-21-005814 |
| FY 2019Yearly · 2019-12-31 | Geography | Foreign | 1,423,000 | USD | 0001493152-21-005814 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 2,092,000 | USD | 0001493152-21-005814 |
| FY 2018Yearly · 2018-12-31 | Product | Grant | 3,572,000 | USD | 0001493152-20-003818 |
| FY 2018Yearly · 2018-12-31 | Product | Royalties From Product Sales And License Fees | 392,000 | USD | 0001493152-20-003818 |
| FY 2018Yearly · 2018-12-31 | Product | Sale Of Research Products And Services | 333,000 | USD | 0001493152-20-003818 |
| FY 2018Yearly · 2018-12-31 | Product | Subscription And Advertisement | 691,000 | USD | 0001493152-20-003818 |
| FY 2018Yearly · 2018-12-31 | Geography | Foreign | 3,184,000 | USD | 0001493152-20-003818 |
| FY 2018Yearly · 2018-12-31 | Geography | United States | 1,804,000 | USD | 0001493152-20-003818 |
| Q3 2018Quarterly · 2018-09-30 | Geography | Foreign | 579,000 | USD | 0001493152-18-015428 |
| Q3 2018Quarterly · 2018-09-30 | Geography | United States | 403,000 | USD | 0001493152-18-015428 |
| Q2 2018Quarterly · 2018-06-30 | Geography | Foreign | 1,916,000 | USD | 0001493152-18-010859 |
| Q2 2018Quarterly · 2018-06-30 | Geography | United States | 631,000 | USD | 0001493152-18-010859 |
| Q1 2018Quarterly · 2018-03-31 | Geography | Foreign | 194,000 | USD | 0001493152-18-006559 |
| Q1 2018Quarterly · 2018-03-31 | Geography | United States | 507,000 | USD | 0001493152-18-006559 |
| FY 2017Yearly · 2017-12-31 | Geography | Foreign | 1,807,000 | USD | 0001493152-19-003335 |
| FY 2017Yearly · 2017-12-31 | Geography | United States | 1,651,000 | USD | 0001493152-19-003335 |
| Q3 2017Quarterly · 2017-09-30 | Geography | Foreign | 1,479,000 | USD | 0001493152-18-015428 |
| Q3 2017Quarterly · 2017-09-30 | Geography | United States | 209,000 | USD | 0001493152-18-015428 |
| Q2 2017Quarterly · 2017-06-30 | Geography | Foreign | 194,000 | USD | 0001493152-18-010859 |
| Q2 2017Quarterly · 2017-06-30 | Geography | United States | 187,000 | USD | 0001493152-18-010859 |
| Q1 2017Quarterly · 2017-03-31 | Geography | Foreign | 217,000 | USD | 0001493152-18-006559 |
| Q1 2017Quarterly · 2017-03-31 | Geography | United States | 173,000 | USD | 0001493152-18-006559 |
| FY 2016Yearly · 2016-12-31 | Geography | Foreign | 1,426,000 | USD | 0001493152-18-003416 |
| FY 2016Yearly · 2016-12-31 | Geography | United States | 4,497,000 | USD | 0001493152-18-003416 |
| FY 2015Yearly · 2015-12-31 | Geography | Foreign | 1,060,000 | USD | 0001493152-18-003416 |
| FY 2015Yearly · 2015-12-31 | Geography | United States | 5,976,000 | USD | 0001493152-18-003416 |
| FY 2014Yearly · 2014-12-31 | Geography | Asia | 1,658,000 | USD | 0001140361-17-012402 |
| FY 2014Yearly · 2014-12-31 | Geography | Domestic | 3,586,000 | USD | 0001140361-17-012402 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.